The Company
Larimar Therapeutics Inc. (Larimar) is a publicly held clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Our lead product candidate, Nomlabofusp (formerly referred to as CTI-1601), is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN), an essential protein to the mitochondria of patients with Friedreich’s ataxia. Friedreich’s ataxia is a rare, progressive, and fatal disease in which patients are unable to produce sufficient FXN due to genetic abnormality.
The company has assembled an experienced management team, each of whom has over 20 years of pharmaceutical industry experience and has over 50 employees. Their management team, employees, and consultants have significant expertise in discovery, nonclinical and clinical development, regulatory affairs, and the development of manufacturing processes utilizing good manufacturing practices.
The company’s strategy is to become a leader in the treatment of rare diseases by leveraging their technology platform and applying their team’s know-how to the development of nomlabofusp and other future pipeline projects. We are best characterized by entrepreneurial and scientific leadership and a participatory workforce committed to success.
If you are searching for a company where urgency, agility, and commitment to science win the day – we welcome you![
Position Summary
Larimar Therapeutics is seeking an experienced and highly motivated Analytical Scientist to provide scientific and strategic leadership for analytical development activities supporting a late-stage protein therapeutic. Reporting directly to the Head of Analytical Science and Technology, this individual will be responsible for establishing and executing analytical strategies and overseeing analytical method transfer, validation, and lifecycle management activities at external development and contract manufacturing organizations (CDMOs).
The successful candidate will serve as a key technical leader across Drug Substance (DS) and Drug Product (DP) development, providing scientific oversight for analytical method development, qualification, validation, transfer, and ongoing method performance monitoring. This role will work closely with Process Development, Manufacturing, Quality, Regulatory Affairs, and external partners to ensure robust analytical support throughout product development and commercialization.
The ideal candidate possesses deep expertise in protein therapeutic characterization and analytical control strategies, including hands-on experience with chromatographic, electrophoretic, and mass spectrometry-based analytical techniques used to support process development, release testing, comparability assessments, and stability programs.
This individual will have a demonstrated track record of leading analytical activities for protein therapeutic programs from development through clinical manufacturing, with experience supporting regulatory submissions and health authority interactions. Experience serving in a CMC leadership role, such as Program Team Leader or CMC program Lead, is highly desirable.
Job Duties and Responsibilities
Analytical Development Leadership
CMC and Program Leadership
Job details are sourced from the employer's original posting.
Open job postingAbout the company
This company is identified by a UUID and its specific business is not immediately clear from the provided information.